Skip to main content
Log in

In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant k-ras genes

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The specific anti-tumor immune response induced by mouse bone marrow dendritic cells (DCs) transfected with recombinant adenovirus carrying mutant k-ras genes was investigated. DCs were generated from mouse bone marrow in the presence of rmGM-CSF (3.3 ng/mL) and rmIL-4 (1.3 ng/mL) and detected by FACS, and then transfected with the recombinant adenovirus encoding mutant k-ras gene. The efficacy of transfection and T cell stimulating activity of DCs were detected. CTL activity of the mice vaccinated with DCs was observed. The results showed that DCs had dendritic veiled morphology. BmDCs highly expressed B7-1 (80%), B7-2 (77%), MHC II (70%), CD11c (65%), CD40 (70%) and CD54 (96%) with FACS, and no significant difference in the expression was observed before and after the transfection (P>0.05). The DCs transfected by mutant k-ras gene could significantly stimulate lymphocytes proliferation as compared with those transfected by Ad-c or non-modified DCs (P<0.05). DC vaccine transfected by mutant k-ras gene could induce CTL activity against Lewis lung cancer, but not against B16. The specific cytotoxicity against Lewis lung cancer in Ad-k-ras/12-transduced DC group was significantly higher than those in the control, vector and non-transfected DCs groups (P<0.05). It was concluded that special antitumor response could be induced by DCs transfected with recombinant adenovirus carrying mutant k-ras genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrams S I, Stanziale S F, Lunin S Det al. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses. Eur J Immunol. 1996,26:435

    Article  PubMed  CAS  Google Scholar 

  2. Bergmann-Leitner E S, Kantor J A, Lesley Shupert Wet al. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele. Celluar Immunology, 1998,187:103

    Article  CAS  Google Scholar 

  3. Bos J L. ras oncogenes in human cancer: a review. Cancer Res, 1989,49:4682

    PubMed  CAS  Google Scholar 

  4. Ramakrishna G, Sithanandam G, Cheng R Yet al. K-ras p21 expression and activity in lung and lung tumors. Exp Lung Res, 2000,26:659

    Article  PubMed  CAS  Google Scholar 

  5. Abrams S I, Dobrzanski M J, Wells D Tet al. Peptide-specific activation of cytolytic CD4 + T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur J Immunol, 1995,25:2588

    Article  PubMed  CAS  Google Scholar 

  6. Banchereau J, Steinman R M. Dendritic cells and the control of immunity. Nature, 1998,392:245

    Article  PubMed  CAS  Google Scholar 

  7. Zhao F, Zhou Q H, Qing Yet al. Construction of mutant k-ras gene recombinant adenovirus. Chin J Lung Cancer (Chinese), 2002,5(1):14

    CAS  Google Scholar 

  8. Jackson J H, Cochrane C G, Bourne J Ret al. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci U S A, 1990,87:3042

    Article  PubMed  CAS  Google Scholar 

  9. He T C, Zhou S, Costa L Tet al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A, 1998,95:2509

    Article  PubMed  CAS  Google Scholar 

  10. Inaba K, Inaba M, Romani Net al. Generation of large number of dendritic cells from mouse bone marrow cultures supplement with GM-CSF. J Exp Med, 1992, 176(6):1693

    Article  PubMed  CAS  Google Scholar 

  11. Hunger R E, Brand C U, Streit Met al. Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant. Exp Dermatol, 2001,10(3): 161

    Article  PubMed  CAS  Google Scholar 

  12. Linard B, Bezieau S, Benlalam Het al. A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion. J Immunol, 2002, 168:4802

    PubMed  CAS  Google Scholar 

  13. Zhong L, Granelli-Piperno A, Choi Yet al. Recombinant adenovirus is an efficient and nonperturbing genetic vector for human dendritic cells. Eur J Immunol, 1999,29:964

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Zhao Feng, male, born in 1971, Doctor in Charge, M. D., Ph.D.

This project was supported by a grant from National Sciences Foundation of China (No. 30000206).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, Z., Qinghua, Z., Yanrong, L. et al. In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant k-ras genes. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 25, 378–381 (2005). https://doi.org/10.1007/BF02828201

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02828201

Key words

Navigation